Porvair (LSE:PRV) reported a 14% increase in revenue at constant currency for the nine months ended 31 August 2026, including organic growth of 5%, as acquisitions contributed to the specialist filtration group’s performance.
The company now expects full-year trading to be slightly ahead of market expectations, supported by demand across its aerospace, nuclear and aluminium-related businesses.
The January acquisition of Drache contributed to revenue growth during the period, while Porvair completed its acquisition of GV Filtri in September, expanding its industrial filtration operations.
Trading conditions remained mixed across the group’s end-markets, with demand in life sciences and environmental testing remaining stable, while some industrial, automotive and European markets continued to experience weaker activity.
Revenue Increases 14% at Constant Currency
Porvair reported constant currency revenue growth of 14% for the first nine months of its financial year, with organic growth accounting for 5%.
The results included a contribution from Drache, which the group acquired in January 2026.
Porvair said demand remained supportive in aerospace, nuclear and aluminium-related markets, while its life sciences and environmental testing businesses continued to trade steadily.
However, the company reported subdued activity in certain industrial and automotive markets, alongside challenging conditions in Europe.
Following the nine-month performance, management revised its full-year outlook and now expects trading to be slightly ahead of market expectations.
Aerospace and Industrial Division Reports Continued Nuclear Demand
Porvair’s Aerospace & Industrial division reported continued demand from its nuclear customers, while aerospace order books remained at elevated levels.
Petrochemical sales remained subdued during the period.
The company also identified difficult trading conditions in European industrial markets, which it expects to continue into 2027.
In September, Porvair completed the acquisition of GV Filtri, adding industrial filtration capabilities and expanding the division’s operations.
The acquisition forms part of the group’s strategy of developing its specialist filtration portfolio through targeted purchases.
Laboratory Division Records Life Sciences Consumables Growth
Porvair’s Laboratory division reported growth in life sciences consumables during the nine-month period.
Demand in environmental testing markets remained stable, while the company said its planned new product introductions were progressing according to schedule.
The division supplies filtration, laboratory and environmental technology products to specialist customers, including those operating in life sciences and analytical testing.
Porvair continues to develop its product portfolio through new introductions alongside its existing consumables business.
Drache Integration Progresses in Metal Melt Quality
The Metal Melt Quality division reported trading slightly ahead of expectations, supported by demand from aluminium-related markets.
Porvair said the integration of Drache, acquired in January 2026, was progressing according to plan.
The acquisition contributed to the group’s reported revenue growth during the nine months to August.
The division supplies specialist filtration and related products used in metal processing, including aluminium and superalloy applications.
Management continues to integrate Drache into the business as part of its acquisition strategy.
Full-Year Trading Expected to Exceed Market Expectations
Porvair has upgraded its outlook for the full financial year and now expects trading to be slightly ahead of market expectations.
The revised guidance reflects the group’s nine-month performance, including organic revenue growth, contributions from Drache and demand across several of its specialist markets.
The company has not provided a specific revised revenue or profit forecast in the supplied announcement.
Aerospace order books, nuclear demand and aluminium-related activity remain supportive of the outlook, while weaker conditions in industrial, automotive and European markets continue to affect parts of the portfolio.
Outlook
Porvair’s priorities for the remainder of the financial year include completing the integration of Drache, incorporating GV Filtri into its industrial filtration operations and progressing new product introductions in Laboratory.
The group expects trading for the full year to be slightly ahead of market expectations, although it anticipates that European industrial conditions will remain challenging into 2027.
Its three divisions — Aerospace & Industrial, Laboratory and Metal Melt Quality — continue to serve a range of specialist markets, with the company’s growth strategy combining organic development and acquisitions.
Leave a Reply